Benjamin M Althouse
Overview
Explore the profile of Benjamin M Althouse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
2306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cecilia H, Althouse B, Azar S, Moehn B, Yun R, Rossi S, et al.
iScience
. 2024 Nov;
27(11):111198.
PMID: 39555418
Viruses transmitted by mosquitoes (e.g., dengue [DENV], Zika [ZIKV]) have demonstrated high potential to spill over from their ancestral, sylvatic cycles in non-human primates to establish transmission in humans. Epidemiological...
2.
Klein B, Hartle H, Shrestha M, Zenteno A, Barros Sierra Cordera D, Nicolas-Carlock J, et al.
PNAS Nexus
. 2024 Sep;
3(9):pgae306.
PMID: 39285936
During outbreaks of emerging infectious diseases, internationally connected cities often experience large and early outbreaks, while rural regions follow after some delay. This hierarchical structure of disease spread is influenced...
3.
Banho C, de Carvalho Marques B, Sacchetto L, Lima A, Parra M, Lima A, et al.
NPJ Vaccines
. 2024 Aug;
9(1):145.
PMID: 39127725
Since 2021, the emergence of variants of concern (VOC) has led Brazil to experience record numbers of in COVID-19 cases and deaths. The expanded spread of the SARS-CoV-2 combined with...
4.
Althouse B, Wallace B, Case B, Scarpino S, Allard A, Berdahl A, et al.
BMC Glob Public Health
. 2024 May;
1(1):28.
PMID: 38798822
Background: Controlling the spread of infectious diseases-even when safe, transmission-blocking vaccines are available-may require the effective use of non-pharmaceutical interventions (NPIs), e.g., mask wearing, testing, limits on group sizes, venue...
5.
Cecilia H, Althouse B, Azar S, Moehn B, Yun R, Rossi S, et al.
bioRxiv
. 2024 Apr;
PMID: 38559148
The contact structure between vertebrate hosts and arthropod vectors plays a key role in the spread of arthropod-borne viruses (arboviruses); thus, it is important to determine whether arbovirus infection of...
6.
Hanley K, Cecilia H, Azar S, Moehn B, Gass J, Oliveira da Silva N, et al.
Nat Commun
. 2024 Mar;
15(1):2682.
PMID: 38538621
Mosquito-borne dengue (DENV) and Zika (ZIKV) viruses originated in Old World sylvatic (forest) cycles involving monkeys and canopy-living Aedes mosquitoes. Both viruses spilled over into human transmission and were translocated...
7.
Banho C, de Carvalho Marques B, Sacchetto L, Lima A, Parra M, Lima A, et al.
Res Sq
. 2024 Feb;
PMID: 38343798
Since 2021, the emergence of variants of concern (VOC) has led Brazil to experience record numbers of in COVID-19 cases and deaths. The expanded spread of the SARS-CoV-2 combined with...
8.
Pollett S, Johansson M, Reich N, Brett-Major D, Del Valle S, Venkatramanan S, et al.
PLoS Med
. 2023 Nov;
20(11):e1004316.
PMID: 37976465
[This corrects the article DOI: 10.1371/journal.pmed.1003793.].
9.
Hanley K, Cecilia H, Azar S, Moehn B, Yu W, Yun R, et al.
bioRxiv
. 2023 Jul;
PMID: 37425901
Mosquito-borne dengue (DENV) and Zika (ZIKV) viruses originated in Old World sylvatic cycles involving monkey hosts, spilled over into human transmission, and were translocated to the Americas, creating potential for...
10.
Smits P, Gratzl S, Simonov M, Nachimuthu S, Goodwin Cartwright B, Wang M, et al.
Vaccine
. 2023 Feb;
41(15):2447-2455.
PMID: 36803895
Background: The successful development of multiple COVID-19 vaccines has led to a global vaccination effort to reduce severe COVID-19 infection and mortality. However, the effectiveness of the COVID-19 vaccines wane...